Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, with the Singapore International Commercial Court (SICC) having…






